US FDA Grants Orphan Drug Status To Sanofi's GPRC5D-Targeting Monoclonal Antibody ...

Retrieved on: 2025-08-01 11:31:05

Tags for this article:

Click the tags to see associated articles and topics

US FDA Grants Orphan Drug Status To Sanofi's GPRC5D-Targeting Monoclonal Antibody .... View article details on hiswai:

Excerpt

FDA granted Orphan Drug Designation to Sanofi's SAR446523, a monoclonal antibody targeting GPRC5D, for relapsed/refractory multiple myeloma, ...

Article found on: www.outlookindia.com